We integrate computational power and biological data to discover life-transforming RNAi medicines
We use our HepNetTM computational biology platform to model disease complexity, generate millions of therapeutic hypotheses in silico, and identify and rank potential novel gene targets. Our proprietary GalOmicTM RNAi platform then enables us to generate GalNAc-siRNA medicines that specifically silence novel genes targets identified by HepNetTM.
Our medicines are designed to silence genes expressed in hepatocytes (liver cells), which perform key functions in biological processes vital for human health and represent important targets for a broad range of diseases.
Unique convergence of two cutting-edge technologies
Our hepatocyte-focused computational biology platform that enables identification of novel gene targets, improves drug design, and increases automation.Learn more
Better medicines faster
Solve human disease through computation
Integrating computational power and biological data to discover life-transforming RNAi medicines
Build an in-house pipeline of more effective medicines at a greater speed and significantly reduced costs compared to industry standards